AstraZeneca’s chief executive has said Europe risks losing its “health sovereignty” and historic strength in pharmaceuticals if it does not pay more for medicines, as the industry shifts investment to the US and China.
“You still see a large industrial base in Europe, for historical reasons. A problem is future products rely on new technologies that require new manufacturing tools,” he said. “And these technologies are going to the US, and they’re going to China and other parts of the world, so into 15, 20 years, Europe could easily lose its health sovereignty.”
How about “If you want to sell medications on the European market, you have to produce at least X% locally”?